Pages that link to "Q36941550"

The following pages link to Humanization of immunotoxins (Q36941550):

Displaying 32 items.

• Improving the efficacy of antibody-based cancer therapies (Q28208361) (← links)
• Recombinant human monoclonal antibodies. Basic principles of the immune system transferred to E. coli (Q30782676) (← links)
• Creating and engineering human antibodies for immunotherapy (Q30874943) (← links)
• Angiogenin: a review of the pathophysiology and potential clinical applications (Q33999348) (← links)
• Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents (Q34288915) (← links)
• Ribonucleases and their antitumor activity (Q34312761) (← links)
• Antibody targeted therapeutics for lymphoma: new focus on the CD22 antigen and RNA. (Q34452700) (← links)
• Preparation of recombinant RNase single-chain antibody fusion proteins (Q34550950) (← links)
• Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins (Q35174521) (← links)
• Building Antibodies from their Genes (Q35180027) (← links)
• The transferrin receptor and the targeted delivery of therapeutic agents against cancer. (Q36406637) (← links)
• Cloning and cytotoxicity of a human pancreatic RNase immunofusion (Q36872924) (← links)
• Engineering antibodies for imaging and therapy (Q36877861) (← links)
• Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity (Q37233080) (← links)
• Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies (Q37394278) (← links)
• Antibody–Enzyme Fusion Proteins for Cancer Therapy (Q37842324) (← links)
• Secretion of functional anti-CD30-angiogenin immunotoxins into the supernatant of transfected 293T-cells. (Q40654829) (← links)
• The new antibody technologies. (Q40876696) (← links)
• Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins (Q42154053) (← links)
• Targeting enzymes for cancer therapy: old enzymes in new roles (Q42590388) (← links)
• Design of a modular immunotoxin connected by polyionic adapter peptides (Q44356443) (← links)
• Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen (Q44899131) (← links)
• CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL. (Q50918966) (← links)
• Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation (Q50985152) (← links)
• Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells. (Q54261268) (← links)
• A Study of the Intracellular Routing of Cytotoxic Ribonucleases (Q56750596) (← links)
• Targeted therapeutic RNases (ImmunoRNases) (Q58008126) (← links)
• Regulated secretion and purification of recombinant antibodies inE. coli (Q58008344) (← links)
• Engineering Antibodies for Therapy (Q67470988) (← links)
• Deoxyribonuclease I (DNAse I). A novel approach for targeted cancer therapy (Q72208060) (← links)
• Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice (Q73387919) (← links)
• Multiple reactive immunization towards the hydrolysis of organophosphorus nerve agents: hapten design and synthesis (Q77181872) (← links)